Novo Nordisk noted during the companys earnings call on August 7 that demand is still expected to surpass supply, but the company is continuing to focus on expanding supply so more patients can access its medications
Methylcobalamin or sublingual forms bypass gastric absorption and may prove more effective for individuals on GLP-1 therapy
They might also affect platelet count
The rising use of these treatments in patients without diabetes has increased demand and raised questions about access for those with diabetes and obesity
This article examines how semaglutide may contribute to acid reflux, reviews clinical evidence, and provides practical strategies for symptom management while maintaining therapeutic benefits
As their use grows, many people are wondering if they are safe after breast cancer, whether they might influence cancer outcomes and not just weight, and what researchers are currently studying to help answer those questions